Meta-Flux Raises $2M to Scale “AI Biologist” for Preclinical Drug Development

Meta-Flux, a Dublin-based biotech startup, has raised €1.8M ($2 million) in seed funding to expand its decision-support platform for preclinical drug development, bridging the gap between preclinical research and clinical application. The round includes backing from senior executives at Pfizer, Merck, and Gilead Sciences, along with technology lead...

• Published date: 13-10-2025 04:00 PM